Literature DB >> 2578781

Monoclonal antibodies directed to E1 glycoprotein of rubella virus.

Y Umino, T A Sato, S Katow, T Matsuno, A Sugiura.   

Abstract

We have prepared four monoclonal antibodies to rubella virus E1 glycoprotein. Three nonoverlapping antigenic sites were delineated on E1 protein by competitive binding assays. Antibodies binding to one site were characterized by high hemagglutination inhibition (HI) titer but poor neutralizing activity. The addition of antiglobulin conferred neutralizing activity. Antibodies directed to two other antigenic sites had modest hemolysis inhibition but little or no HI and neutralizing activities. The addition of antiglobulin markedly augmented HI activity but had little effect on neutralizing activity. Epitopes defined by three antibodies were conserved among four rubella virus strains examined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578781     DOI: 10.1007/bf01310962

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

1.  Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.

Authors:  A Schluederberg; D M Horstmann; W A Andiman; M F Randolph
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Hemolysis-inhibition test for detection of rubella antibody.

Authors:  N Kobayashi; M Suzuki; M Matumoto
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.

Authors:  A L Schmaljohn; K M Kokubun; G A Cole
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

5.  Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines.

Authors:  H Sakata; M Hishiyama; A Sugiura
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

6.  Immunochemical identification of rubella virus hemagglutinin.

Authors:  M N Waxham; J S Wolinsky
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

7.  Base composition of rubella virus RNA. Brief report.

Authors:  S Katow; T Matsuno
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM.

Authors:  R S Tedder; J L Yao; M J Anderson
Journal:  J Hyg (Lond)       Date:  1982-04

9.  Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.

Authors:  C Oker-Blom; N Kalkkinen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

10.  Immunological characterisation of rubella virion polypeptides.

Authors:  L Ho-Terry; A Cohen; R S Tedder
Journal:  J Med Microbiol       Date:  1984-02       Impact factor: 2.472

View more
  12 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

Authors:  L Lozzi; M Rustici; M Corti; M G Cusi; P E Valensin; L Bracci; A Santucci; P Soldani; A Spreafico; P Neri
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Anti-idiotypic antibodies to rubella virus.

Authors:  A Nath; B Slagle; J S Wolinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Immunological characterisation of the rubella E 1 glycoprotein. Brief report.

Authors:  L Ho-Terry; G M Terry; A Cohen; P Londesborough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Localization of the rubella E1 epitopes.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.

Authors:  C Lindqvist; M Schmidt; J Heinola; R Jaatinen; M Osterblad; A Salmi; S Keränen; K Akerman; C Oker-Blom
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine.

Authors:  M G Cusi; G M Rossolini; C Cellesi; P E Valensin
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Detection of rubella virus-specific immunoglobulin M antibodies with a baculovirus-expressed E1 protein.

Authors:  M Schmidt; C Lindqvist; A Salmi; C Oker-Blom
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

9.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.